window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 21, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

AI in Pharma

  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Uncategorised

    Veeva unveils bold vision for simplifying, standardising, and AI-powered innovation

    In a keynote address that signaled both reflection and momentum, [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data

    Clinical trial innovation hampered by change fatigue and skills gaps, survey finds

    A new survey from eClinical Solutions reveals that biopharma organizations [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain

    Lonza launches Design2Optimize platform to accelerate API development

    Lonza has unveiled a new model-based development platform, Design2Optimize, which [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development

    Pharma’s innovation blind spot: Why speed and business model agility will define the next decade

    Pharmaceutical innovation is at a critical inflection point. Most companies [...]

    May 5, 2026
  • Advanced Therapies,Digital & Data,Drug Discovery & Development

    Alchemab strikes $415m licensing deal with Lilly for ALS candidate ATLX-1282

    UK-based Alchemab Therapeutics has signed a landmark licensing agreement with [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development

    QuantHealth introduces clinical-stage AI foundation model for trial design

    The new platform, trained on 100 million patient records, aims [...]

    May 5, 2026
  • Digital & Data

    EXCLUSIVE: How agentic AI Is transforming medical affairs: A conversation with Sorcero CEO Dipanwita Das

    Artificial intelligence (AI) is reshaping the pharmaceutical industry, with agentic [...]

    May 5, 2026
  • Digital & Data

    Indegene outlines critical GenAI lessons and strategies for the future of life sciences

    May 5, 2026
Previous23

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Alto Neuroscience raises $100M to expand Phase 3 treatment-resistant depression programme
    Categories: Biotech & Pharma Business, Central Nervous System
  • EC approves first targeted first-line treatment for BRAF-mutant metastatic colorectal cancer
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
  • FDA grants Fast Track status to SOTIO’s colorectal cancer ADC ahead of Phase 1/2 trial
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top